Glycosphingolipids mediate Pneumocystis cell wall β-glucan activation of the IL-23/IL-17 axis in human dendritic cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 1, 2012, Pages 50-59

  Carmona, Eva M ^a   Kottom, Theodore J ^a   Hebrink, Deanne M ^a   Moua, Teng ^a   Singh, Raman Deep ^a   Limper, Andrew H ^a  

^a MAYO CLINIC   (United States)

Author keywords

glucan; Dendritic cells; IL 17; IL 23; Pneumocystis

Indexed keywords

BETA GLUCAN; DECTIN 1; GLYCOSPHINGOLIPID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; LACTOSYLCERAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE SYK;

ARTICLE; BACTERIAL CELL WALL; CELL ACTIVATION; CELL INTERACTION; CELL MEMBRANE; CELL POLARITY; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PHENOTYPE; PNEUMOCYSTIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TH1 CELL; TH17 CELL;

BETA-GLUCANS; CELL WALL; CELLS, CULTURED; DENDRITIC CELLS; GLYCOSPHINGOLIPIDS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; INTERLEUKINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS, C-TYPE; MEMBRANE MICRODOMAINS; NF-KAPPA B; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS;

PNEUMOCYSTIS;

EID: 84863798906     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0159OC     Document Type: Article

References (68)

1. Baar HS. Interstitial plasmacellular pneumonia due to Pneumocystis carinii. J Clin Pathol 1955;8:19-24.
2. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in aids. Jama 1988;259:1185-1189. (Pubitemid 18058829)
3. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;111:223-231. (Pubitemid 19190915)
4. Dungarwalla M, Marsh JC, Tooze JA, Lucas G, Ouwehand W, Pettengell R, Dearden CE, Gordon Smith EC, Elebute MO. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Ann Hematol 2007;86:191-197. (Pubitemid 46195991)
5. Harigai M, Koike R, Miyasaka N. Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med 2007;357:1874-1876. (Pubitemid 350044826)
6. Kalyoncu U, Karadag O, Akdogan A, Kisacik B, Erman M, Erguven S, Ertenli AI. Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab. Scand J Infect Dis 2007;39:475-478. (Pubitemid 46705764)
7. Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007;52:1481-1484. (Pubitemid 46776482)
8. Kolstad A, Holte H, Fossa A, Lauritzsen GF, Gaustad P, Torfoss D. Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-choep-14 regimen. Haematologica 2007;92: 139-140. (Pubitemid 46232678)
9. Lahiff C, Khiaron OB, Nolan N, Chadwick GA. Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis. Ir J Med Sci 2007;176:309-311. (Pubitemid 350182773)
10. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996;71:5-13. (Pubitemid 26021784)
11. Thomas CF, Jr., Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-2498.
12. + T cell-independent DNA vaccination against opportunistic infections. J Clin Invest 2005;115:3536-3544.
13. Carmona EM, Limper AH. Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis 2011;5:41-59.
14. AbuAttieh M, Rebrovich M, Wettstein PJ, Vuk-Pavlovic Z, Limper AH, Platt JL, Cascalho M. Fitness of cell-mediated immunity independent of repertoire diversity. J Immunol 2007;178:2950-2960. (Pubitemid 46333174)
15. Limper AH, Offord KP, Smith TF, Martin WJ Jr. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204-1209. (Pubitemid 19276197)
16. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003;278:1910-1914. (Pubitemid 36801431)
17. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, et al. Impaired T(h) 17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008;452:773-776. (Pubitemid 351521078)
18. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008;205:1551-1557. (Pubitemid 351962018)
19. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004;190:624-631. (Pubitemid 38982105)
20. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C, Mosci P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007;37:2695-2706. (Pubitemid 47578289)
21. Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007;75:3055-3061. (Pubitemid 46870190)
22. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-189. (Pubitemid 43214587)
23. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942-949. (Pubitemid 47300008)
24. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(h)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967-974. (Pubitemid 47300011)
25. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006;177:566-573. (Pubitemid 43939170)
26. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003;171:6173-6177. (Pubitemid 37467240)
27. Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 2006;36:2857-2867. (Pubitemid 44782559)
28. Duffus JH, Levi C, Manners DJ. Yeast cell-wall glucans. Adv Microb Physiol 1982;23:151-181.
29. Kottom TJ, Limper AH. Cell wall assembly by Pneumocystis carinii. evidence for a unique GSC-1 subunit mediating beta-1,3-glucan deposition. J Biol Chem 2000;275:40628-40634. (Pubitemid 32064703)
30. Shematek EM, Braatz JA, Cabib E. Biosynthesis of the yeast cell wall: I. Preparation and properties of beta-(1 leads to 3)glucan synthetase. J Biol Chem 1980;255:888-894. (Pubitemid 10108130)
31. Carmona EM, Vassallo R, Vuk-Pavlovic Z, Standing JE, Kottom TJ, Limper AH. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism. J Immunol 2006;177:459-467. (Pubitemid 43939159)
32. Lebron F, Vassallo R, Puri V, Limper AH. Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J Biol Chem 2003;278:25001-25008. (Pubitemid 37548662)
33. Vassallo R, Standing J, Limper AH. Beta-glucan from Pneumocystis carinii stimulates TNF alpha release from alveolar macrophages. J Eukaryot Microbiol 1999;46:145S. (Pubitemid 29471801)
34. Vassallo R, Standing JE, Limper AH. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 2000;164:3755-3763. (Pubitemid 30169832)
35. Carmona EM, Lamont JD, Xue A, Wylam M, Limper AH. Pneumocystis cell wall beta-glucan stimulates calcium-dependent signaling of IL-8 secretion by human airway epithelial cells. Respir Res 2010;11:95.
36. Hahn PY, Evans SE, Kottom TJ, Standing JE, Pagano RE, Limper AH. Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide- mediated mechanism. J Biol Chem 2003;278:2043-2050. (Pubitemid 36801448)
37. Evans SE, Hahn PY, McCann F, Kottom TJ, Pavlovic ZV, Limper AH. Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. Am J Respir Cell Mol Biol 2005;32:490-497. (Pubitemid 40770126)
38. Sheets ED, Holowka D, Baird B. Membrane organization in immunoglobulin e receptor signaling. Curr Opin Chem Biol 1999;3:95-99. (Pubitemid 29118987)
39. Janes PW, Ley SC, Magee AI, Kabouridis PS. The role of lipid rafts in T cell antigen receptor (TCR) signalling. Semin Immunol 2000;12:23-34. (Pubitemid 30114013)
40. Cheng PC, Dykstra ML, Mitchell RN, Pierce SK. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 1999;190:1549-1560. (Pubitemid 30002337)
41. Limper AH, Hoyte JS, Standing JE. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest 1997;99:2110-2117. (Pubitemid 27203767)
42. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez- Pomares L, Wong SY, Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 2002;196:407-412. (Pubitemid 34875669)
43. Brown GD, Gordon S. Immune recognition: a new receptor for beta-glucans. Nature 2001;413:36-37. (Pubitemid 32843478)
44. Leibund Gut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007;8:630-638. (Pubitemid 46785127)
45. Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA, Taylor PR, Kerrigan A, Tsoni SV, Gordon S, Meyer-Wentrup F, et al. Syk kinase is required for collaborative cytokine production induced through dectin-1 and Toll-like receptors. Eur J Immunol 2008;38:500-506.
46. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SC, Geijtenbeek TB. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 2009;10:203-213.
47. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009;27:693-733.
48. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071. (Pubitemid 27163860)
49. Solan NJ, Miyoshi H, Carmona EM, Bren GD, Paya CV. RELB cellular regulation and transcriptional activity are regulated by p100. J Biol Chem 2002;277:1405-1418. (Pubitemid 34968896)
50. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-572. (Pubitemid 27248754)
51. Iwabuchi K, Nagaoka I. Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 2002;100:1454-1464. (Pubitemid 34864305)
52. Brown DA. Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 2006;21:430-439. (Pubitemid 44879252)
53. Rajendran L, Simons K. Lipid rafts and membrane dynamics. J Cell Sci 2005;118:1099-1102. (Pubitemid 40528680)
54. Singh RD, Holicky EL, Cheng ZJ, Kim SY, Wheatley CL, Marks DL, Bittman R, Pagano RE. Inhibition of caveolar uptake, SV40 infection, and beta1-integrin signaling by a nonnatural glycosphingolipid stereoisomer. J Cell Biol 2007;176:895-901. (Pubitemid 46506963)
55. McCann F, Carmona E, Puri V, Pagano RE, Limper AH. Macrophage internalization of fungal beta-glucans is not necessary for initiation of related inflammatory responses. Infect Immun 2005;73:6340-6349. (Pubitemid 41368795)
56. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009;31:331-341.
57. Kolls JK, Kanaly ST, Ramsay AJ. Interleukin-17: an emerging role in lung inflammation. Am J Respir Cell Mol Biol 2003;28:9-11. (Pubitemid 36017045)
58. Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am J Respir Cell Mol Biol 1997;17:491-500. (Pubitemid 127500982)
59. Beck JM, Harmsen AG. Lymphocytes in host defense against Pneumocystis carinii. Semin Respir Infect 1998;13:330-338. (Pubitemid 28560101)
60. Leibundgut-Landmann S, Osorio F, Brown GD, Reis e Sousa C. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 2008;112:4971-4980.
61. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007;26:605-616. (Pubitemid 46756345)
62. Underhill DM. Collaboration between the innate immune receptors dectin-1, TLRS, and NODS. Immunol Rev 2007;219:75-87. (Pubitemid 47390003)
63. Cheng ZJ, Singh RD, Wang TK, Holicky EL, Wheatley CL, Bernlohr DA, Marks DL, Pagano RE. Stimulation of GLUT4 (glucose transporter isoform 4) storage vesicle formation by sphingolipid depletion. Biochem J 2010;427:143-150.
64. Rosenwald AG, Machamer CE, Pagano RE. Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway. Biochemistry 1992;31:3581-3590.
65. Chen CS, Rosenwald AG, Pagano RE. Ceramide as a modulator of endocytosis. J Biol Chem 1995;270:13291-13297.
66. Rosenwald AG, Pagano RE. Effects of the glucosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells. J Lipid Res 1994;35:1232-1240. (Pubitemid 24209397)
67. Wang J, Gigliotti F, Bhagwat SP, Maggirwar SB, Wright TW. Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 2007;292:L1495-1505. (Pubitemid 47077367)
68. Lasbury ME, Durant PJ, Ray CA, Tschang D, Schwendener R, Lee CH. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with Pneumocystis pneumonia. J Immunol 2006;176:6443-6453. (Pubitemid 43787826)